Trials / Completed
CompletedNCT02614781
Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 892 (actual)
- Sponsor
- Nordic Pharma SAS · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a non-interventional prospective, multicenter, longitudinal study conducted in France, among a representative sample of public and/or private birth control centers. The aim of the study is to assess, in real-life settings, the success rate of the protocol Mifegyne / prostaglandin analogue in patients asking for medical abortion either prior or beyond 7 weeks of amenorrhea.
Conditions
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-11-25
- Last updated
- 2016-07-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02614781. Inclusion in this directory is not an endorsement.